We recently published Ten big names that will fall apart before 2026. ASP Isotopes Inc. (NASDAQ:ISP) had one of the worst results on Tuesday.
ASP Isotopes extended its losing streak to a third day on Tuesday, losing 5.08 percent to close at $5.42 apiece, as investors reflected a key executive’s willingness to take a significant stake in the company.
In a regulatory filing on Monday, ASP Isotopes Inc. (NASDAQ:ISP) said its chief financial officer, Heather Kiessling, disposed of 80,000 shares at a weighted average price of $5.798 each on Dec. 18.
Syda Productions/Shutterstock.com
The executive did not reveal the reason for the sale, which left her with 732,500 shares remaining.
Added to this confidence was the lack of new events that would drive purchases.
In its latest announcement earlier this month, ASP Isotopes Inc. (NASDAQ:ISP) said it had successfully obtained all regulatory approval for its planned acquisition of Renergen Ltd. in an all-stock deal.
Under the agreement, ASP Isotopes Inc. (NASDAQ:ISP) would pay Renergen shareholders 0.09196 new shares of ASP Isotopes for each unit they own.
Renergen is a public company dedicated to the production of liquefied helium (LHe) and liquefied natural gas (LNG), and is financed by the United States government, given the strategic importance of helium.
The two parties believed that their merger would create a global leader in the production of critical and strategically important materials, including electronic gases such as helium, various fluorinated products, and isotopically enriched gases.
While we recognize the potential of ISPs as an investment, our conviction lies in the belief that some AI stocks have more promise to generate higher returns and have limited downside risk. If you’re looking for an extremely cheap AI stock that’s also one of the biggest beneficiaries of Trump’s tariffs and offshoring, check out our free report on the best short-term AI stock.
READ NEXT: 30 stocks that should double in 3 years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article was originally published in Internal jumpsuit.